Mononuclear-cell immunisation in prevention of recurrent miscarriages: A randomised trial

Lancet

Volumn 354, Issue 9176, 1999, Pages 365-369

  Ober, Carole ^a   Karrison, Theodore ^a   Odem, Randall R ^b   Barnes, Randall B ^a   Branch, D Ware ^c   Stephenson, Mary D ^d   Baron, Beverly ^a   Walker, Mary Ann ^a   Scott, James R ^c   Schreiber, James R ^b  

^a Departments of Medicine and Human Genetics   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; MULTICENTER STUDY; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT ABORTION; SPONTANEOUS ABORTION;

EID: 0033620817     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)12055-X     Document Type: Article

References (27)

1. Warburton D., Fraser F.C. Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. Am J Hum Genet. 41:1964;1-24.
2. Stray-Pederson B., Stray-Pederson S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol. 148:1984;140-146.
3. Alberman E. The epidemiology of repeated abortions. Beard R.W., Sharp F. Early pregnancy loss: mechanisms of treatment. 1988;9-17 Springer-Verlag, London.
4. Tho T.P., Byrd J.R., McDonough P.G. Etiologies and subsequent reproductive performance of 100 couples with recurrent abortion. Fertil Steril. 32:1979;389-395.
5. Harger J.H., Archer D.F., Marchese S.G.et al. Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies. Obstet Gynecol. 62:1983;574-581.
6. Hill J.A., Polgar K., Harlow B.L., Anderson D.J. Evidence of embryo and trophoblast toxic cellular immune response(s) in women with recurrent spontaneous abortion. Am J Obstet Gynecol. 166:1992;1044-1052.
7. Beer A.E., Billingham R.E. The immunobiology of reproduction. 1976;Prentice Hall, Upper Saddle River.
8. Faulk W.P., Johnson P.M. Immunological studies of human placentae: basic and practical implications. Thompson R.A. Recent Advances in Clinical Immunology. 1980;1-31 Churchill Livingstone, New York.
9. Taylor C.G., Faulk W.P., McIntyre J.A. Prevention of recurrent spontaneous abortions by leukocyte transfusions. J R Soc Med. 78:1985;623-627.
10. Beer A.E., Quebbeman J.F., Ayers J.W.T., Haines R.F. Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. Am J Obstet Gynecol. 141:1981;987-997.
11. Mowbray J.F., Liddell H., Underwood J.L.et al. Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet. i:1985;941-943.
12. Cauchi M.N., Lim D., Kloss Y.M., Pepperell R.J. Treatment of recurrent aborters by immunization with paternal cells - controlled trial. Am J Reprod Immunol. 25:1991;16-17.
13. Ho H.N., Gill T.J. Immunotherapy for recurrent spontaneous abortion in a Chinese population. Am J Reprod Immunol. 25:1991;10-15.
14. Gatenby P.A., Cameron K., Simes R.J.et al. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial. Am J Reprod Immunol. 29:1993;88-94.
15. Fraser E.J., Grimes D.A., Schulz K.F. Immunization as a therapy for recurrent abortion: a review and meta-analysis. Obstet Gynecol. 82:1993;854-859.
16. Illeni M.T., Marelli G., Parazzini F.et al. Immunotherapy and recurrent abortion: a randomized clinical trial. Hum Reprod. 7:1994;1247-1249.
17. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol. 32:1994;55-72.
18. Jeng G.T., Scott J.R., Burmeister L.F. A comparison of meta-analytic results using literature vs individual patient data. JAMA. 274:1995;830-836.
19. The ASHI Laboratory Manual. 3rd:1995;American Society for Histocompatibility and Immunogenetics, New York.
20. Jordon J., Craig K., Clifton D.K., Soules M.R. Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertil Steril. 62:1994;54-62.
21. Chedid A., Chadalawada K.R., Morgan R.R.et al. Phospholipid antibodies in alcoholic liver disease. Hepatology. 20:1994;1465-1471.
22. Lachin J.M., Matts J.P., Wei L.J. Randomization in clinical trials: conclusions and recommendations. Control Clin Trials. 9:1988;365-374.
23. Branch D.W., Silver R.M. Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss? Lupus. 5:1996;409-413.
24. O'Brien P.C., Fleming T.R. A multiple testing procedure for clinical trials. Biometrics. 35:1979;549-556.
25. Warburton D., Kline J., Stein Z., Strobino B. Cytogenetic abnormalities in spontaneous abortions of recognized conceptions. 1986;Academic Press, Orlando.
26. Warburton D., Fraser F.C. On the probability that a woman who has had a spontaneous abortion will abort subsequent pregnancies. Br J Obstet Gynaecol. 68:1961;784-787.
27. Karrison T., Ober C. Recurrent Miscarriage (REMIS) Study: how should data from women who do not become pregnant be handled? Control Clin Trials. 19:1998;430-439.